InvestSMART

XRF Scientific Limited (ASX: XRF) - Announcements

- Current share price for XRF : $2.120

ASX company news and announcements for XRF Scientific Limited (XRF) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All XRF Scientific Limited (XRF) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than XRF Scientific Limited (XRF), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for XRF Scientific Limited (XRF)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$307 Shareholder Update - Profit Guidance 2011 13 Oct 2010 11:43AM $0.170 $2.120 risen by 1,147.06%
$307 Preliminary Final Report - Appendix 4E 27 Aug 2010 6:41PM $0.165 $2.120 risen by 1,184.85%
$307 XRF $7m Acquisition of Sigma Flux and Precious Metals 30 Jul 2010 9:14AM $0.165 $2.120 risen by 1,184.85%
$307 Trading Halt 28 Jul 2010 2:25PM $0.150 $2.120 risen by 1,313.33%
$307 Company Update - June 2010 25 Jun 2010 6:58PM $0.150 $2.120 risen by 1,313.33%
$307 Response to Media Speculation 17 Jun 2010 1:44PM $0.150 $2.120 risen by 1,313.33%
$307 Trading Halt 16 Jun 2010 10:03AM $0.145 $2.120 risen by 1,362.07%
$307 Purchase/Supply Agreement Signed with International Company 1 Mar 2010 5:14PM $0.175 $2.120 risen by 1,111.43%
$307 Appendix 4D - December 2009 Half Year Accounts 19 Feb 2010 7:15PM $0.175 $2.120 risen by 1,111.43%
$307 Company Update - Preliminary half-year results 28 Jan 2010 12:56PM $0.150 $2.120 risen by 1,313.33%
$307 December 09 Company Update 8 Dec 2009 12:08PM $0.190 $2.120 risen by 1,015.79%
$307 MoU Signed with International Company 16 Sep 2009 10:06AM $0.160 $2.120 risen by 1,225%
$307 Preliminary Final Report - Appendix 4E 31 Aug 2009 9:27AM $0.160 $2.120 risen by 1,225%
$307 Preliminary 2009 Results - Declaration of Final Dividend 29 Jul 2009 9:21AM $0.130 $2.120 risen by 1,530.77%
$307 20 Year Australian Patents Granted to XRF 25 May 2009 9:16AM $0.115 $2.120 risen by 1,743.48%
$307 Appendix 4C - quarterly 28 Apr 2009 9:40AM $0.110 $2.120 risen by 1,827.27%
$307 Appendix 4D - December 2008 Half Year Report 27 Feb 2009 9:32AM $0.098 $2.120 risen by 2,063.27%
$307 Preliminary Earnings Guidance - Half Year to 31 December 08 18 Feb 2009 9:43AM $0.100 $2.120 risen by 2,020%
$307 Appendix 4C - quarterly 30 Jan 2009 9:27AM $0.100 $2.120 risen by 2,020%
$307 Appendix 4C - quarterly 31 Oct 2008 9:36AM $0.110 $2.120 risen by 1,827.27%
$307 First major sales to South American clients 24 Sep 2008 11:38AM $0.135 $2.120 risen by 1,470.37%
$307 Declares Maiden Dividend 16 Sep 2008 11:07AM $0.115 $2.120 risen by 1,743.48%
$307 Preliminary Final Report 27 Aug 2008 9:12AM $0.110 $2.120 risen by 1,827.27%
$307 Appendix 4C - quarterly 31 Jul 2008 1:52PM $0.100 $2.120 risen by 2,020%
$307 First Sales to China and Iran 25 Jun 2008 3:05PM n/a $2.120 n/a

351 - 375 of 392 results

Page 15 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.